Back to Search
MARK HANCOCK, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1003954637IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
H5450(TX)104112(MT)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Class of 1987
Research & Publications (20)
Cell confinement in patterned nanoliter droplets in a microwell array by wiping.
PMID 19585570·J Biomed Mater Res A·2010
7-preclinical
A hollow sphere soft lithography approach for long-term hanging drop methods.
PMID 19505251·Tissue Eng Part C Methods·2010
7-preclinical
Local suppression of T cell responses by arginase-induced L-arginine depletion in nonhealing leishmaniasis.
PMID 19597544·PLoS Negl Trop Dis·2009
7-preclinical
A guide to interpretation of studies investigating subgroups of responders to physical therapy interventions.
PMID 19465372·Phys Ther·2009
6-review
High-throughput screening compatible cell-based assay for interrogating activated notch signaling.
PMID 19382889·Assay Drug Dev Technol·2009
8-other
Rapid generation of spatially and temporally controllable long-range concentration gradients in a microfluidic device.
PMID 19255657·Lab Chip·2009
7-preclinical
Definitions of recurrence of an episode of low back pain: a systematic review.
PMID 19531986·Spine (Phila Pa 1976)·2009
1-meta
Can rate of recovery be predicted in patients with acute low back pain? Development of a clinical prediction rule.
PMID 18448369·Eur J Pain·2009
2-rct
Characterization of the interferon regulatory factor 3-mediated antiviral response in a cell line deficient for IFN production.
PMID 19038458·Mol Immunol·2009
7-preclinical
On "clinical prediction rules for physical therapy interventions..." Beneciuk JM, et al. Phys Ther. 2009;89:114-124.
PMID 19339250·Phys Ther·2009
8-other
Cell fusion-induced activation of interferon-stimulated genes is not required for restriction of a herpes simplex virus VP16/ICP0 mutant in heterokarya formed between permissive and restrictive cells.
PMID 19535444·J Virol·2009
7-preclinical
Mutation in the LPS outer core biosynthesis gene, galU, affects LPS interaction with the RTX toxins ApxI and ApxII and cytolytic activity of Actinobacillus pleuropneumoniae serotype 1.
PMID 18713318·Mol Microbiol·2008
7-preclinical
Isolation and characterization of alpha-enolase, a novel fibronectin-binding protein from Streptococcus suis.
PMID 18757800·Microbiology (Reading)·2008
7-preclinical
Presynaptic type III neuregulin 1 is required for sustained enhancement of hippocampal transmission by nicotine and for axonal targeting of alpha7 nicotinic acetylcholine receptors.
PMID 18784291·J Neurosci·2008
7-preclinical
Independent evaluation of a clinical prediction rule for spinal manipulative therapy: a randomised controlled trial.
PMID 18427840·Eur Spine J·2008
2-rct
Presynaptic type III neuregulin1-ErbB signaling targets {alpha}7 nicotinic acetylcholine receptors to axons.
PMID 18458158·J Cell Biol·2008
7-preclinical
Presynaptic type III neuregulin1-ErbB signaling targets alpha7 nicotinic acetylcholine receptors to axons.
PMID 18504310·J Gen Physiol·2008
8-other
TonB induces conformational changes in surface-exposed loops of FhuA, outer membrane receptor of Escherichia coli.
PMID 18653801·Protein Sci·2008
8-other
A systematic review of paracetamol for non-specific low back pain.
PMID 18797937·Eur Spine J·2008
1-meta
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 931 HIGHLAND BLVD STE 3130
BOZEMAN, MT 59715 - Phone
- (406) 414-3130
Quick Facts
- NPI
- 1003954637
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 39
- Publications
- 20
Are you this provider?
Claim Your Profile